TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2047-783X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway ; volume:28 ; number:1 ; day:27 ; month:1 ; year:2023 ; pages:1-12 ; date:12.2023
European journal of medical research ; 28, Heft 1 (27.1.2023), 1-12, 12.2023

Creator: Ye, Yanqing
Liu, Maosheng
Wu, Fengfei
Ou, Shiyu
Wang, Weidong
Fei, Jieying
Xie, Fang
Bai, Lan

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40001-022-00951-1

URN: urn:nbn:de:101:1-2023040321434506073199

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ye, Yanqing
Liu, Maosheng
Wu, Fengfei
Ou, Shiyu
Wang, Weidong
Fei, Jieying
Xie, Fang
Bai, Lan
SpringerLink (Online service)

Other Objects (12)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”

Midkine promotes glioblastoma progression via PI3K-Akt signaling

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN

SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling

Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”

Midkine promotes glioblastoma progression via PI3K-Akt signaling

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN

SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling

Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”

Midkine promotes glioblastoma progression via PI3K-Akt signaling

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN

SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling

Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”

Midkine promotes glioblastoma progression via PI3K-Akt signaling

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN

SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling

Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”

Midkine promotes glioblastoma progression via PI3K-Akt signaling

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN

SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling

Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”

Midkine promotes glioblastoma progression via PI3K-Akt signaling

Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway

MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN

SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway

SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling

Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway

GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway

Related objects

Reset password